期刊
ORAL ONCOLOGY
卷 49, 期 6, 页码 560-566出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.oraloncology.2013.03.446
关键词
Human papillomavirus; Head and neck cancer; HNSCC; Chemoradiation; Cisplatin; Cetuximab; Prognosis
资金
- CTMM, the Centre for Translational Molecular Medicine, AIRFORCE project [03O-103]
Objectives: Infection with the human papillomavirus (HPV) is an important risk factor for development of head and neck squamous cell carcinoma (HNSCC). Strikingly, HPV-positive HNSCCs have a more favorable prognosis than their HPV-negative counterparts. The current study was designed to explain this favorable prognosis of HPV-positive HNSCC. Materials and methods: This was performed by investigating the response of four HPV-positive and fourteen HPV-negative HNSCC cell lines to cisplatin, cetuximab and radiation. Results: Analysis of the responses of this cell line panel indicated that HPV-positive cells are more resistant to cisplatin treatment than the HPV-negative HNSCCs, whereas the response to radiation and cetuximab did not differ. Conclusions: The current study suggests that the favorable prognosis for patients with HPV-positive HNSCC does not seem to be related to an intrinsic sensitivity of these tumor cells to chemotherapy or radiation in vitro. (C) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据